119 related articles for article (PubMed ID: 33356882)
1. Evaluation of the antithrombogenicity of poly-2-methoxyethylacrylate-coated catheters.
Kariya S; Nakatani M; Maruyama T; Ono Y; Ueno Y; Komemushi A; Tanigawa N
J Vasc Access; 2022 Jan; 23(1):117-122. PubMed ID: 33356882
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Antithrombogenicity of a Poly-2-Methoxyethylacrylate-Coated Central Venous Port-Catheter System.
Kariya S; Nakatani M; Ono Y; Maruyama T; Ueno Y; Komemushi A; Tanigawa N
Cardiovasc Intervent Radiol; 2020 May; 43(5):775-780. PubMed ID: 32055927
[TBL] [Abstract][Full Text] [Related]
3. PMEA polymer-coated PVC tubing maintains anti-thrombogenic properties during in vitro whole blood circulation.
Yoshizaki T; Tabuchi N; van Oeveren W; Shibamiya A; Koyama T; Sunamori M
Int J Artif Organs; 2005 Aug; 28(8):834-40. PubMed ID: 16211534
[TBL] [Abstract][Full Text] [Related]
4. Hemocompatibility of PMEA coated oxygenators used for extracorporeal circulation procedures.
Zimmermann AK; Aebert H; Reiz A; Freitag M; Husseini M; Ziemer G; Wendel HP
ASAIO J; 2004; 50(3):193-9. PubMed ID: 15171468
[TBL] [Abstract][Full Text] [Related]
5. New surface biopolymers for oxygenators: an in vitro hemocompatibility test of poly(2-methoxyethylacrylate).
Baykut D; Bernet F; Wehrle J; Weichelt K; Schwartz P; Zerkowski HR
Eur J Med Res; 2001 Jul; 6(7):297-305. PubMed ID: 11485890
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of antithrombogenicity of a new heparinized hydrophilic polymer: chronic in vivo studies and clinical application.
Idezuki Y; Watanabe H; Hagiwara M; Kanasugi K; Mori Y
Trans Am Soc Artif Intern Organs; 1975; 21():436-49. PubMed ID: 1146018
[TBL] [Abstract][Full Text] [Related]
7. [In vivo evaluation of the new antithrombogenic reservoir-catheter coated with polymer blend copolymer].
Matsumoto S; Yamada Y; Kiyosue H; Dono S; Mori H; Imagawa M; Nomura Y; Toyoda H; Shimada T
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Apr; 57(5):238-43. PubMed ID: 9164111
[TBL] [Abstract][Full Text] [Related]
8. In vivo comparison study of FDA-approved surface-modifying additives and poly-2-methoxyethylacrylate circuit surfaces coatings during cardiopulmonary bypass.
Ask A; Holt D; Smith L
J Extra Corpor Technol; 2006 Mar; 38(1):27-32. PubMed ID: 16637520
[TBL] [Abstract][Full Text] [Related]
9. Poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit can reduce transfusion of platelet products compared to heparin-coated circuit during aortic arch surgery.
Hosoyama K; Ito K; Kawamoto S; Kumagai K; Akiyama M; Adachi O; Kawatsu S; Sasaki K; Suzuki M; Sugawara Y; Shimizu Y; Saiki Y
J Artif Organs; 2016 Sep; 19(3):233-40. PubMed ID: 26909493
[TBL] [Abstract][Full Text] [Related]
10. Effects of new polymer-coated extracorporeal circuits on biocompatibility during cardiopulmonary bypass.
Saito N; Motoyama S; Sawamoto J
Artif Organs; 2000 Jul; 24(7):547-54. PubMed ID: 10916066
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of poly(2-methoxyethylacrylate) in primary coronary artery bypass grafting.
Vang SN; Brady CP; Christensen KA; Isler JR; Allen KR
J Extra Corpor Technol; 2005 Mar; 37(1):23-31. PubMed ID: 15804153
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelium damage from catheter-induced mechanical stimulation causes catheter sleeve formation in a rabbit model.
Tanabe H; Takemura N; Terao H; Hagiwara H; Zushi Y; Murayama R; Abe-Doi M; Sanada H
J Vasc Access; 2020 May; 21(3):379-386. PubMed ID: 31591941
[TBL] [Abstract][Full Text] [Related]
13. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
[TBL] [Abstract][Full Text] [Related]
14. Heparin-coated angiographic catheters: an in vivo comparison of three coating methods with different heparin release profiles.
Lee KH; Han JK; Byun Y; Moon HT; Yoon CJ; Kim SJ; Choi BI
Cardiovasc Intervent Radiol; 2004; 27(5):507-11. PubMed ID: 15383856
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of antithrombogenic thermodilution catheter.
Nagaoka S; Mikami M; Noishiki Y
J Biomater Appl; 1989 Jul; 4(1):22-32. PubMed ID: 2746466
[TBL] [Abstract][Full Text] [Related]
16. In vivo rabbit acute model tests of polyurethane catheters coated with a novel antithrombin-heparin covalent complex.
Du YJ; Klement P; Berry LR; Tressel P; Chan AK
Thromb Haemost; 2005 Aug; 94(2):366-72. PubMed ID: 16113827
[TBL] [Abstract][Full Text] [Related]
17. Poly2-methoxyethylacrylate (PMEA) coated oxygenator: an ex vivo study.
Mueller XM; Jegger D; Augstburger M; Horisberger J; von Segesser LK
Int J Artif Organs; 2002 Mar; 25(3):223-9. PubMed ID: 11999195
[TBL] [Abstract][Full Text] [Related]
18. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
[TBL] [Abstract][Full Text] [Related]
19. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
[TBL] [Abstract][Full Text] [Related]
20. Heparin release from thermosensitive polymer coatings: in vivo studies.
Gutowska A; Bae YH; Jacobs H; Mohammad F; Mix D; Feijen J; Kim SW
J Biomed Mater Res; 1995 Jul; 29(7):811-21. PubMed ID: 7593019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
